Canadian amiodarone myocardial infarction arrhythmia trial (CAMIAT)

From Aaushi
Jump to navigation Jump to search

Introduction

Amiodarone did not improve overall mortality after myocardial infarction.

More general terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 67